The Recall Desk

State

Kansas product recalls

73,833 recalls have nationwide distribution and so reach Kansas. 5,822 additional recalls listed Kansas specifically in their distribution scope.

What the numbers show

Total
5,822
Critical
1,053
Severe
1,486
Most recent
2026-11-04

Of the 5,822 recalls naming Kansas we have scored against our rubric, 1,053 (18%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,486 (26%) are Severe.

These figures cover only the 5,822 recalls whose distribution notice names Kansas specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

59226–59250 of 79655

  • SevereFDA (Drugs)·D-917-2015·2015-04-29

    Attix Pharmaceuticals Recalls Telaprevir API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Telaprevir active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-729-2015·2015-04-29

    Attix Pharmaceuticals Recalls Idoxuridine Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Idoxuridine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Idoxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-690-2015·2015-04-29

    Attix Pharmaceuticals Recalls Fluticasone Propionate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Fluticasone Propionate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Fluticasone Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-902-2015·2015-04-29

    Attix Pharmaceuticals Recalls Sorafenib API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Sorafenib active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Sorafenib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-595-2015·2015-04-29

    Attix Pharmaceuticals Recalls Clomipramine HCI Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Clomipramine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Clomipramine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-950-2015·2015-04-29

    Attix Pharmaceuticals Recalls Vardenafil HCl Trihydrate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Vardenafil HCl Trihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Vardenafil HCl Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-737-2015·2015-04-29

    Attix Pharmaceuticals Recalls Isosorbide Dinitrate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Isosorbide Dinitrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Isosorbide Dinitrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-892-2015·2015-04-29

    Attix Pharmaceuticals Recalls Sevelamer HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Sevelamer HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Sevelamer HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-824-2015·2015-04-29

    Attix Pharmaceuticals Recalls Omeprazole Sodium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Omeprazole Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Omeprazole Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-592-2015·2015-04-29

    Attix Pharmaceuticals Recalls Clarithromycin Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of clarithromycin active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Clarithromycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-708-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hyaluronic Acid Sodium Salt Injection Grade API

    Attix Pharmaceuticals is recalling Hyaluronic Acid Sodium Salt (Injection Grade) active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Hyaluronic Acid Sodium Salt (Injection Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-927-2015·2015-04-29

    Attix Pharmaceuticals Recalls Thiotepa Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Thiotepa active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Thiotepa active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1472-2015·2015-04-29

    Churchill Medical Systems Recalls 8 Inch Standard Bore Extension Sets

    Churchill Medical Systems is recalling 8-inch Standard Bore Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and the female luer.

    Product
    8" Standard Bore Ext Set, Product Code: BN-481 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1474-2015·2015-04-29

    Churchill Medical Systems Recalls 7-Inch High Pressure Extension Sets

    Churchill Medical Systems is recalling 6,850 units of 7-inch Standard Bore High Pressure Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and female luer.

    Product
    7" Standard Bore High Pressure Ext Set, Product Code: CMS-809 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-876-2015·2015-04-29

    Attix Pharmaceuticals Recalls Rebamipide Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Rebamipide API distributed between January 2012 and February 2015 due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Rebamipide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-869-2015·2015-04-29

    Progesterone API Recalled for Potential Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling progesterone active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Progesterone Ultra-Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-833-2015·2015-04-29

    Attix Pharmaceuticals Recalls Paroxetine Active Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling paroxetine active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Paroxetine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-545-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bismuth Subcarbonate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bismuth Subcarbonate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Bismuth Subcarbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1471-2015·2015-04-29

    Churchill Medical 4-inch Microbore T-Port Set Recalled for Leaking Risk

    Churchill Medical Systems is recalling 450 units of 4-inch Microbore T-Port Sets due to a potential leak caused by insufficient bonding between components.

    Product
    4" Microbore T-Port Set, Product Code: BN-448 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1495-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Dimensional Defects

    Wright Medical Technology is recalling 308 units of the Crosscheck Plating System because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, Utility Plate, 3-Hole, REF CCP-UTN3. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-579-2015·2015-04-29

    Attix Pharmaceuticals Recalls Chloroquine Phosphate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Chloroquine Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Chloroquine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-522-2015·2015-04-29

    Attix Pharmaceuticals Recalls Anastrozole API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Anastrozole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Anastrozole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-852-2015·2015-04-29

    Attix Pharmaceuticals Recalls Povidone K-30 Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Povidone K-30 pharmaceutical ingredient lots distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.

    Product
    Povidone K-30 pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1496-2015·2015-04-29

    Wright Medical Recalls Crosscheck Plating System Due to Specification Defects

    Wright Medical Technology is recalling 372 units of the Crosscheck Plating System because dimensional specifications are out of tolerance, posing a risk of intraoperative malfunction.

    Product
    CROSSCHECK(R) Plating system, Utility Plate, 4-Hole, REF CCP-UTN4. Orthopedic use.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1475-2015·2015-04-29

    Churchill Medical Systems Recalls 7-inch High Pressure Extension Sets

    Churchill Medical Systems is recalling 6,850 units of 7-inch Standard Bore High Pressure Extension Sets due to a potential leak caused by insufficient bonding.

    Product
    7" Standard Bore High Pressure Ext Set, Product Code: CMS-809 Accessory device used to administer medical fluids
    Category
    Medical Device
    Distribution
    Distributed nationwide